HAE - Company ID 0000313143
The table below shows HAEMONETICS CORP's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $245.44M | $306.76M | $178.80M | $284.47M | $259.50M | $192.31M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $216.85M | $202.66M | $206.56M | $179.14M | $159.38M | $127.56M |
| Inventory | $306.37M | $365.14M | $317.20M | $259.38M | $293.03M | $322.61M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $834.88M |
| $934.98M |
| $768.90M |
| $769.72M |
| $756.03M |
| $693.55M |
| Property, plant & equipment | $305.76M | $284.05M | $311.36M | $310.88M | $258.48M | $217.56M |
| Goodwill | $656.37M | $604.27M | $565.08M | $466.23M | $467.29M | $466.44M |
| Total assets | $2.40B | $2.45B | $2.20B | $1.93B | $1.86B | $1.82B |
| Accounts payable | $51.06M | $67.00M | $73.36M | $63.93M | $58.37M | $50.29M |
| Total current liabilities | $282.60M | $578.11M | $300.38M | $251.82M | $442.27M | $253.50M |
| Long-term debt | $1.22B | $921.23M | $797.56M | $754.10M | $559.44M | $690.59M |
| Total liabilities | - | - | - | - | - | - |
| Retained earnings | $279.34M | $352.17M | $360.46M | $253.17M | $202.39M | $157.98M |
| Total equity | $796.32M | $820.84M | $959.96M | $818.00M | $749.42M | $731.67M |